Fluzone High Dose Northern Hemisphere
Product Images NDC 49281-125

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone High Dose Northern Hemisphere (NDC 49281-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Label for FLUZONE HIGH DOSE NORTHERN HEMISPHERE influenza vaccine 2023-2024 formula, 0.5 mL single-dose syringe. The label indicates it contains no preservative, is for intramuscular use, and intended for individuals 65 years and older. Manufactured by Sanofi Pasteur Inc. It includes the NDC barcode and placeholders for lot and expiration dates.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

Packaging label for FLUZONE HIGH DOSE NORTHERN HEMISPHERE influenza vaccine 2023-2024 formula. The label shows the product is for adults 65+, with 10 single-dose prefilled syringes of 0.5 mL each for intramuscular use. Labeler is Sanofi Pasteur Inc. Storage and usage instructions, plus vaccine strain information, are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.